Healthpeak Properties, Inc. $DOC Shares Sold by Cullen Capital Management LLC

Key Points

• Cullen Capital Management reduced its Healthpeak Properties stake by 11.1% in the second quarter, selling 1.22 million shares and retaining 9.77 million shares valued at approximately $209 million.
• Healthpeak reported quarterly revenue of $771.6 million and adjusted earnings of $0.08 per share, beating analyst expectations, while revenue increased 11.1% year over year. The company maintained fiscal 2026 guidance of $1.73–$1.77 in earnings per share.
• Analysts remain broadly neutral, with a consensus “Hold” rating and a $21.66 target price. Healthpeak also declared a monthly dividend of $0.1017 per share, representing an indicated 5.6% yield.

Cullen Capital Management LLC reduced its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 11.1% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,768,642 shares of the real estate investment trust's stock after selling 1,222,659 shares during the period. Healthpeak Properties makes up about 2.1% of Cullen Capital Management LLC's holdings, making the stock its 17th biggest holding. Cullen Capital Management LLC owned approximately 1.42% of Healthpeak Properties worth $209,049,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of DOC. Integrated Wealth Concepts LLC grew its stake in Healthpeak Properties by 7.3% during the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust's stock valued at $366,000 after purchasing an additional 1,231 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Healthpeak Properties by 110.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust's stock worth $2,463,000 after purchasing an additional 63,930 shares during the last quarter. Woodline Partners LP raised its position in shares of Healthpeak Properties by 41.3% in the 1st quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust's stock valued at $1,195,000 after purchasing an additional 17,279 shares in the last quarter. Brown Advisory Inc. raised its position in shares of Healthpeak Properties by 3.1% in the 2nd quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust's stock valued at $819,000 after purchasing an additional 1,415 shares in the last quarter. Finally, Qube Research & Technologies Ltd acquired a new position in shares of Healthpeak Properties in the 2nd quarter valued at approximately $3,117,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Stock Performance

Healthpeak Properties stock opened at $21.62 on Tuesday. The company has a market cap of $14.91 billion, a PE ratio of 61.77, a P/E/G ratio of 2.50 and a beta of 1.01. The company has a fifty day moving average price of $21.41 and a two-hundred day moving average price of $19.07. The company has a debt-to-equity ratio of 1.06, a current ratio of 3.02 and a quick ratio of 3.02. Healthpeak Properties, Inc. has a 12 month low of $15.70 and a 12 month high of $22.95.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The firm had revenue of $771.58 million during the quarter, compared to analyst estimates of $725.64 million. During the same quarter in the previous year, the firm earned $0.46 earnings per share. The firm's revenue for the quarter was up 11.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Research analysts expect that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be given a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 5.6%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties's dividend payout ratio is currently 348.57%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on DOC. Citigroup raised their price target on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock a "neutral" rating in a research report on Tuesday, August 11th. JPMorgan Chase & Co. upped their price target on shares of Healthpeak Properties from $18.00 to $21.00 and gave the company a "neutral" rating in a report on Wednesday, June 24th. Royal Bank Of Canada increased their price objective on shares of Healthpeak Properties from $21.00 to $24.00 and gave the company an "outperform" rating in a research note on Monday, August 10th. Barclays assumed coverage on shares of Healthpeak Properties in a research note on Tuesday, July 7th. They set an "equal weight" rating and a $23.00 price objective on the stock. Finally, Robert W. Baird boosted their target price on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an "outperform" rating in a research report on Thursday, August 13th. Four research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company. Based on data from MarketBeat.com, Healthpeak Properties has a consensus rating of "Hold" and a consensus target price of $21.66.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source